Jain A et al. |
Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation. |
2001 |
Pediatr Transplant |
pmid:11328546
|
Frühwirth M et al. |
Rotavirus infection as cause of tacrolimus elevation in solid-organ-transplanted children. |
2001 |
Pediatr Transplant |
pmid:11328545
|
Mittal N et al. |
Tacrolimus and diarrhea: pathogenesis of altered metabolism. |
2001 |
Pediatr Transplant |
pmid:11328543
|
Dicarlo JB and McCall CO |
Pharmacologic alternatives for severe atopic dermatitis. |
2001 |
Int. J. Dermatol. |
pmid:11328387
|
Mollee P et al. |
Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis. |
2001 |
Br. J. Haematol. |
pmid:11328304
|
Sche PP et al. |
Corrigendum to: "Display cloning: functional identification of natural product receptors using cDNA-phage display" [Chemistry & Biology 6 (1999) 707-716]. |
2001 |
Chem. Biol. |
pmid:11325595
|
Kawada N et al. |
Role of mast cells in antigen-induced airway inflammation and bronchial hyperresponsiveness in rats. |
2001 |
Jpn. J. Pharmacol. |
pmid:11325017
|
Kulkarni P |
Review: uveitis and immunosuppressive drugs. |
2001 |
J Ocul Pharmacol Ther |
pmid:11324985
|
Weinberg JM and Silverberg NB |
A kinder, gentler therapy? |
2001 |
Cutis |
pmid:11324387
|
Kennedy DS and Linden GJ |
Resolution of gingival overgrowth following change from cyclosporin to tacrolimus therapy in a renal transplant patient. |
2000 |
J Ir Dent Assoc |
pmid:11323935
|
Lang-Lazdunski L et al. |
The effects of FK506 on neurologic and histopathologic outcome after transient spinal cord ischemia induced by aortic cross-clamping in rats. |
2001 |
Anesth. Analg. |
pmid:11323353
|
Gaziev D and Lucarelli G |
Novel approaches to the treatment of chronic graft-versus-host disease. |
2001 |
Expert Opin Investig Drugs |
pmid:11322865
|
StrestÃková P et al. |
Different mechanisms in inhibition of rat macrophage nitric oxide synthase expression by FK 506 and cyclosporin A. |
2001 |
Immunopharmacol Immunotoxicol |
pmid:11322650
|
Russell RK et al. |
Systemic absorption with complications during topical tacrolimus treatment for orofacial Crohn disease. |
2001 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:11321395
|
Pohanka E et al. |
[Dosage and monitoring of tacrolimus after kidney transplantation]. |
2000 |
Dtsch. Med. Wochenschr. |
pmid:11320722
|
Smith KM and Van Etten RA |
Activation of c-Abl kinase activity and transformation by a chemical inducer of dimerization. |
2001 |
J. Biol. Chem. |
pmid:11320088
|
Takatsuki M et al. |
Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance. |
2001 |
Transpl. Immunol. |
pmid:11316071
|
Yoshimoto T et al. |
Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat. |
2001 |
Brain Res. |
pmid:11311876
|
Rumora L et al. |
MKP-1 as a target for pharmacological manipulations in PC12 cell survival. |
2001 |
Neurochem. Int. |
pmid:11311446
|
Freyschmidt-Paul P et al. |
Current and potential agents for the treatment of alopecia areata. |
2001 |
Curr. Pharm. Des. |
pmid:11311114
|
Monegal A et al. |
Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. |
2001 |
Calcif. Tissue Int. |
pmid:11310351
|
Sheehy EC et al. |
Oral health in children undergoing liver transplantation. |
2000 |
Int J Paediatr Dent |
pmid:11310095
|
|
Topical tacrolimus for treatment of atopic dermatitis. |
2001 |
Med Lett Drugs Ther |
pmid:11309535
|
Jones NF et al. |
Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation. |
2001 |
Plast. Reconstr. Surg. |
pmid:11304605
|
Trotter JF et al. |
Liver transplantation using sirolimus and minimal corticosteroids (3-day taper). |
2001 |
Liver Transpl. |
pmid:11303295
|
Mardini M et al. |
Cyclosporine and FK506 differentially regulate the sarcolemmal Na(+)-K(+) pump. |
2001 |
J. Pharmacol. Exp. Ther. |
pmid:11303073
|
Shiraishi S et al. |
Up-regulation of cell surface sodium channels by cyclosporin A, FK506, and rapamycin in adrenal chromaffin cells. |
2001 |
J. Pharmacol. Exp. Ther. |
pmid:11303055
|
Arima H et al. |
Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus. |
2001 |
J. Pharmacol. Exp. Ther. |
pmid:11303042
|
Li S et al. |
Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism. |
2001 |
Exp. Hematol. |
pmid:11301194
|
Luger T et al. |
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. |
2001 |
Br. J. Dermatol. |
pmid:11298538
|
Harper J et al. |
First experience of topical SDZ ASM 981 in children with atopic dermatitis. |
2001 |
Br. J. Dermatol. |
pmid:11298537
|
Griffiths CE |
Ascomycin: an advance in the management of atopic dermatitis. |
2001 |
Br. J. Dermatol. |
pmid:11298524
|
Yada T et al. |
Its8, a fission yeast homolog of Mcd4 and Pig-n, is involved in GPI anchor synthesis and shares an essential function with calcineurin in cytokinesis. |
2001 |
J. Biol. Chem. |
pmid:11297516
|
Ishikawa M et al. |
[Blood concentrations and side effects of tacrolimus in a living renal transplantation]. |
2001 |
Masui |
pmid:11296433
|
Lener EV et al. |
Successful treatment of erosive lichen planus with topical tacrolimus. |
2001 |
Arch Dermatol |
pmid:11295919
|
Macchi-Andanson M et al. |
Failure of traditional trough levels to predict tacrolimus concentrations. |
2001 |
Ther Drug Monit |
pmid:11294512
|
van Gelder T et al. |
Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. |
2001 |
Ther Drug Monit |
pmid:11294511
|
Fortin JF et al. |
Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1. |
2001 |
Blood |
pmid:11290602
|
Zoeteweij JP et al. |
Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus. |
2001 |
Blood |
pmid:11290600
|
Lunz JG et al. |
Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. |
2001 |
Am. J. Pathol. |
pmid:11290556
|
Fredduzzi S et al. |
Nitro-aspirin (NCX4016) reduces brain damage induced by focal cerebral ischemia in the rat. |
2001 |
Neurosci. Lett. |
pmid:11290402
|
Trimarchi H et al. |
Cyclosporine-associated thrombotic microangiopathy during daclizumab induction: a suggested therapeutic approach. |
2001 |
Nephron |
pmid:11287781
|
Kasper RC et al. |
Anetoderma arising in cutaneous B-cell lymphoproliferative disease. |
2001 |
Am J Dermatopathol |
pmid:11285407
|
Schwrer H et al. |
Pantoprazole and cyclosporine or tacrolimus. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11284790
|
Krisp A and Hoffmann R |
[Letter concerning the article by E.C.Bornhövd, E.Schuller, T.Bieber, A.Wollenberg: "Immunosuppressive macrolides and their use in dermatology". Der Hautarzt (2000) 51:646-654]. |
2001 |
Hautarzt |
pmid:11284076
|
Tahara K et al. |
Experimental small bowel transplantation using newborn intestine in rats: III. Long-term cryopreservation of rat newborn intestine. |
2001 |
J. Pediatr. Surg. |
pmid:11283886
|
Martel J et al. |
[Subcutaneous mycosis due to Scopulariopsis brevicaulis in an immunocompromised patient]. |
2001 |
Ann Dermatol Venereol |
pmid:11275588
|
von Schnakenburg C et al. |
Post-transplant epididymitis and orchitis following Listeria monocytogenes septicaemia. |
2000 |
Pediatr Transplant |
pmid:11272610
|
Dmitrewski J et al. |
Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin? |
1994 |
Transpl. Int. |
pmid:11271342
|
Uemoto S et al. |
Long-term use of FK 506 in living related liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271341
|
Mor E et al. |
Comparison of short and long-term renal function in liver transplant patients receiving cyclosporin or FK 506. |
1994 |
Transpl. Int. |
pmid:11271340
|
Wong P et al. |
FK 506 rescue therapy for intractable liver allograft rejection. |
1994 |
Transpl. Int. |
pmid:11271339
|
Otto G et al. |
Corticosteroids and concomitant medication in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271338
|
Devlin J et al. |
FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. European FK 506 Study Liver Group. |
1994 |
Transpl. Int. |
pmid:11271328
|
Winkler M et al. |
Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271312
|
Moutabarrik A et al. |
Effect of immunosuppressive agents FK 506 and cyclosporin and steroids on the expression of IL-6 and its receptor by stimulated lymphocytes and monocytes. |
1994 |
Transpl. Int. |
pmid:11271305
|
Metcalfe S et al. |
FK 506 and cyclosporin each block antigen-induced T cell receptor signalling that is dependent on CD4 co-receptor and operates in the absence of detectable cytoplasmic calcium fluxes. |
1994 |
Transpl. Int. |
pmid:11271304
|
Platz KP et al. |
Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients. |
1994 |
Transpl. Int. |
pmid:11271297
|
Ishii T et al. |
Immunodepressants ameliorate normothermic ischemia injury to the rat liver by down-regulating tumor necrosis factor, not by alleviation of lipid peroxidative injury. |
1994 |
Transpl. Int. |
pmid:11271294
|
Trocha K et al. |
Neurological examinations after liver transplantation concerning patients under corticosteroid immunosuppression and either FK 506 or cyclosporin. |
1994 |
Transpl. Int. |
pmid:11271273
|
D'Silva M et al. |
The immunomodulatory effects of a novel agent, leflunomide, in rat cardiac allotransplantation. |
1994 |
Transpl. Int. |
pmid:11271257
|
Mueller AR et al. |
Neurotoxicity after orthotopic liver transplantation in cyclosporin A- and FK 506-treated patients. |
1994 |
Transpl. Int. |
pmid:11271254
|
McMaster P |
Patient and graft survival in the European Multicentre Liver Study--FK 506 vs cyclosporin A. |
1994 |
Transpl. Int. |
pmid:11271239
|
Bismuth H et al. |
Focus on intractable rejection: 6-month results of the European multicentre liver study of FK 506 and cyclosporin A. |
1994 |
Transpl. Int. |
pmid:11271231
|
Neuhaus P et al. |
Neurological complications in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271222
|
|
Two-year follow-up study of the efficacy and safety of FK 506 in kidney transplant patients. Japanese FK 506 Study Group. |
1994 |
Transpl. Int. |
pmid:11271216
|
Devlin J et al. |
Renal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipients. |
1994 |
Transpl. Int. |
pmid:11271207
|
Yano K et al. |
Effects of intrahepatic arterial and intraportal administration of FK 506 on liver allograft survival in rats. |
1994 |
Transpl. Int. |
pmid:11271200
|
Undre N and Möller A |
Pharmacokinetic interpretation of FK 506 levels in blood and in plasma during a European randomised study in primary liver transplant patients. The FK 506 European Study Group. |
1994 |
Transpl. Int. |
pmid:11271189
|
Ericzon B et al. |
Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study. |
1994 |
Transpl. Int. |
pmid:11271178
|
Bekersky I et al. |
Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose. |
2001 |
J Clin Pharmacol |
pmid:11269569
|
Jain A et al. |
Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus. |
2001 |
J Clin Pharmacol |
pmid:11269567
|
Reimer J et al. |
Quality of life after kidney transplantation--the impact of tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267573
|
Lo A et al. |
Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267516
|
Spada M et al. |
A cause of late graft dysfunction after liver transplantation in children: de-novo autoimmune hepatitis. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267495
|
Molmenti EP et al. |
Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267487
|
Owen ER et al. |
Peripheral nerve regeneration in human hand transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267484
|
Lo A et al. |
Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267477
|
McCauley J et al. |
Long-term lipid metabolism in combined kidney-pancreas transplant recipients under tacrolimus immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267475
|
Kahl A et al. |
Long-term prednisolone withdrawal after pancreas and kidney transplantation in patients treated with ATG, tacrolimus, and mycophenolate mofetil. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267473
|
Burke GW et al. |
Ten-year survival after simultaneous pancreas/kidney transplantation with bladder drainage and tacrolimus-based immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267467
|
Lo A et al. |
Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267465
|
Jordan ML et al. |
Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267456
|
Treede H et al. |
Incidence and spectrum of infections in lung transplanted patients: comparison of four different immunosuppressive protocols. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267444
|
Mehra MR et al. |
Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267442
|
Mehra MR et al. |
A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267438
|
Banerjee R et al. |
Coadministration of itraconazole and tacrolimus after thoracic organ transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267435
|
Uber PA et al. |
Ethnic disparities in the pharmacologic characteristics of tacrolimus in heart transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267428
|
Rabkin JM et al. |
Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267411
|
Heffron TG et al. |
Daclizumab induction in liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267408
|
Langrehr JM et al. |
A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267404
|
Pirenne J et al. |
Standard cyclosporine A-based versus completely steroid-free FK506-based immunosuppression after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267396
|
van den Berg AP et al. |
Recurrent HCV infection reduces the requirement for tacrolimus after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267375
|
Groetzner J et al. |
Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up? |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267373
|
Heffron TG et al. |
Single-dose induction with daclizumab immediately after liver transplantation in pediatric patients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267368
|
Langrehr JM et al. |
IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267360
|
Markus BH et al. |
Daclizumab induction therapy in combination with tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267354
|
Shokouh-Amiri MH et al. |
The importance of early prevention of renal dysfunction in liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267345
|
Mohamed MA et al. |
TGF-beta expression in protocol transplant liver biopsies: a comparative study between cyclosporine-A (CyA) and tacrolimus (FK 506) immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267336
|
Mueller AR et al. |
Influence of immunosuppression on patient survival after liver transplantation for hepatitis C. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267321
|